^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

PL001

i
Other names: PL001, CD19-targeted chimeric antigen receptor T-cell
Associations
Trials
Company:
Pell Bio-Med Techno
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
Associations
Trials